MUSTER; Thomas

Patent Applications and Registrations

Patent applications and USPTO patent grants for MUSTER; Thomas.The latest application filed is for "high growth influenza virus".

Company Profile

2.31.35

MUSTER; Thomas - Vienna AT
Muster; Thomas - Wien AT
Muster; Thomas - Kassel DE
Muster; Thomas - A-1190 Vienna AT
Muster; Thomas - Graz AT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
High Growth Influenza Virus App 20220160863 - MUSTER; Thomas ; et al.	2022-05-26
Method for influenza virus purification Grant 10,570,376 - Peterka , et al. Feb	2020-02-25
Influenza virus vector for virotherapy Grant 10,480,013 - Muster , et al. Nov	2019-11-19
Novel Influenza Virus Vector For Virotherapy App 20190032084 - Muster; Thomas	2019-01-31
Influenza virus vector for virotherapy Grant 10,125,374 - Muster November 13, 2	2018-11-13
Novel Influenza Virus App 20180016560 - Muster; Thomas ; et al.	2018-01-18
Influenza virus Grant 9,771,564 - Muster , et al. September 26, 2	2017-09-26
Attenuated Negative Strand Viruses With Altered Interferon Antagonist Activity For Use As Vaccines And Pharmaceuticals App 20160279227 - Palese; Peter ; et al.	2016-09-29
Novel Influenza Virus Vector For Virotherapy App 20160264996 - Muster; Thomas	2016-09-15
Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals Grant 9,387,240 - Palese , et al. July 12, 2	2016-07-12
Method For Influenza Virus Purification App 20160002606 - PETERKA; Matjaz ; et al.	2016-01-07
Replication deficient influenza virus for the expression of heterologous sequences Grant 9,187,732 - Wolschek , et al. November 17, 2	2015-11-17
Attenuated Negative Strand Viruses With Altered Interferon Antagonist Activity For Use As Vaccines And Pharmaceuticals App 20140341948 - Palese; Peter ; et al.	2014-11-20
Method for generation of RNA virus Grant 8,778,357 - Muster , et al. July 15, 2	2014-07-15
Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals Grant 8,765,139 - Palese , et al. July 1, 2	2014-07-01
Method for generation of RNA virus Grant 8,741,301 - Muster , et al. June 3, 2	2014-06-03
High growth reassortant influenza A virus Grant 8,691,238 - Muster , et al. April 8, 2	2014-04-08
Replication Deficient Influenza Virus For The Expression Of Heterologous Sequences App 20140045245 - Wolschek; Markus ; et al.	2014-02-13
Antibodies specific for the melanoma-associated endogenous retrovirus (MERV) envelope glycoprotein Grant 8,541,553 - Humer , et al. September 24, 2	2013-09-24
Novel Method For Generation Of Rna Virus App 20130183740 - Muster; Thomas ; et al.	2013-07-18
Plastic profile for window, door and facade elements Grant 8,286,396 - Brunnhofer , et al. October 16, 2	2012-10-16
Attenuated Negative Strand Viruses With Altered Interferon Antagonist Activity For Use As Vaccines And Pharmaceuticals App 20120258134 - PALESE; PETER ; et al.	2012-10-11
Polynucleotide Fragments of an Infectious Human Endogenous Retrovirus App 20120237527 - Wolff; Klaus ; et al.	2012-09-20
Novel Influenza Virus App 20120164175 - Muster; Thomas ; et al.	2012-06-28
Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals Grant 8,057,803 - Palese , et al. November 15, 2	2011-11-15
Immune Response Inducing Preparations App 20110268764 - Sachet; Monika ; et al.	2011-11-03
High Growth Reassortant Influenza A Virus App 20110262481 - Muster; Thomas ; et al.	2011-10-27
Novel Method For Generation Of Rna Virus App 20110250587 - Muster; Thomas ; et al.	2011-10-13
Polynucleotide fragments of an infectious human endogenous retrovirus Grant 8,008,460 - Wolff , et al. August 30, 2	2011-08-30
Melanoma-Associated Endogenous Retrovirus (MERV) Derived Peptide Sequences And Their Therapeutic/Diagnostic Use App 20100285509 - Mayer; Bernd ; et al.	2010-11-11
Novel Methods And Interferon Deficient Substrates For The Propagation Of Viruses App 20100233785 - Brandt; Sabine ; et al.	2010-09-16
Novel Method For Generation Of Rna Virus App 20100184191 - MUSTER; Thomas ; et al.	2010-07-22
Method for influenza virus protection App 20100158944 - Peterka; Matjaz ; et al.	2010-06-24
Attenuated Negative Strand Viruses With Altered Interferon Antagonist Activity For Use As Vaccines And Pharmaceuticals App 20100158942 - Palese; Peter ; et al.	2010-06-24
Antibodies Useful For Therapy And Diagnosis Of Cancer App 20100136518 - Humer; Johannes ; et al.	2010-06-03
Replication Deficient Influenza Virus For The Expression Of Heterologous Sequences App 20100136052 - Wolschek; Markus ; et al.	2010-06-03
Linear Expression Constructs For Production Of Influenza Virus Particles App 20100129399 - Wolschek; Markus ; et al.	2010-05-27
Plastic Profile For Window, Door And Facade Elements App 20100018140 - Brunnhofer; Erwin ; et al.	2010-01-28
Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals Grant 7,588,768 - Palese , et al. September 15, 2	2009-09-15
Polynucleotide Fragments Of An Infectious Human Endogenous Retrovirus App 20090180975 - Wolff; Klaus ; et al.	2009-07-16
Melanoma-associated endogenous retrovirus (MERV) derived peptide sequences and their therapeutic/diagnostic use App 20090130129 - Mayer; Bernd ; et al.	2009-05-21
Immune Response Inducing Preparations App 20090123495 - Sachet; Monika ; et al.	2009-05-14
Polynucleotide fragments of an infectious human endogenous retrovirus Grant 7,510,862 - Wolff , et al. March 31, 2	2009-03-31
Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals App 20090053264 - Palese; Peter ; et al.	2009-02-26
Polynucleotide Fragments of an Infectious Human Endogenous Retrovirus App 20080008717 - Wolff; Klaus ; et al.	2008-01-10
Dithiocarbamate antiviral agents and methods of using same Grant 7,282,599 - Gaudernak , et al. October 16, 2	2007-10-16
Use of a class of antiviral compounds for production of an agent for the treatment or prevention of a viral infection in the respiratory tract App 20060069153 - Gaudernak; Elisabeth ; et al.	2006-03-30
Interferon inducing genetically engineered attenuated viruses Grant 6,866,853 - Egorov , et al. March 15, 2	2005-03-15
Polynucleotide fragments of an infections human endogenous retrovirus App 20040241642 - Wolff, Klaus ; et al.	2004-12-02
Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals App 20040109877 - Palese, Peter ; et al.	2004-06-10
Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals Grant 6,669,943 - Palese , et al. December 30, 2	2003-12-30
Interferon inducing genetically engineered attenuated viruses App 20030157131 - Egorov, Andrei ; et al.	2003-08-21
Genetically engineered attenuated viruses Grant 6,022,726 - Palese , et al. February 8, 2	2000-02-08
HIV-vaccines Grant 5,911,989 - Katinger , et al. June 15, 1	1999-06-15
Peptides that induce antibodies which neutralize genetically divergent HIV-1 isolates Grant 5,866,694 - Katinger , et al. February 2, 1	1999-02-02
Peptides that induce antibodies which neutralize genetically divergent HIV-1 isolates Grant 5,756,674 - Katinger , et al. May 26, 1	1998-05-26
Peptides that induce antibodies which neutralize genetically divergent HIV-1 isolates Grant 5,693,752 - Katinger , et al. December 2, 1	1997-12-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.